Polycystic Ovary Syndrome

Recent Studies by L.A. Stadtmauer and Co-Authors Add New Data to Polycystic Ovary Syndrome Findings

Published in Women's Health Weekly, March 10th, 2011

2011 MAR 10 -- In this recently published article, scientists in the United States conducted a study "To evaluate the effect of the gonadotropin-releasing hormone antagonist Ganirelix on gonadotropin ovulation induction (OI) in patients with polycystic ovary syndrome (PCOS). Prospective, randomized, controlled study."

"Academic infertility center. Ninety-eight anovulatory women with PCOS undergoing 154 gonadotropin OI cycles. Patients were treated with recombinant FSH alone (group 1) or in conjunction with Ganirelix when the leading follicle was R13 mm (group 2) versus from the beginning of stimulation (group 3), followed by IUI. Per cycle clinical...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2011-03-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry